OmniAb
OABI
4.31
-0.26
-5.59%
OmniAb
US · OABI
#3556 by market cap
Listed 2021
4.31
-0.26
-5.59%
Live - 5344 symbols - heartbeat 423s ago
· 2026-10-08 10:00
Pre-market
4.25
-6.80%
After-hours
4.61
+1.10%
- Market cap
- 625.91M
- P/E (TTM)i
- -11.96
- P/Bi
- 2.41
- EPSi
- -0.57
- Div yieldi
- 0.00%
- 52W posi
- 73%
Reader sentiment
Are you bullish or bearish on OABI?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $5 to $11Market Newswire · 2026/8/18
-
Rating change
A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $3 to $11Market Newswire · 2025/8/8
-
Rating change
Leerink Partners Maintains OmniAb(OABI.US) With Buy Rating, Raises Target Price to $10Market Newswire · 2025/5/16
-
Rating change
TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $4Market Newswire · 2025/8/7
-
Rating change
TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $3Market Newswire · 2026/8/7
-
Analysts Are Bullish on These Healthcare Stocks: CapsoVision, Inc. (CV), OmniAb (OABI)TipRanks · 2026/9/30
-
Rating change
Benchmark Co. Maintains OmniAb(OABI.US) With Buy Rating, Cuts Target Price to $4Market Newswire · 2025/11/6
-
Stifel Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $9Market Newswire · 2026/10/7
-
Rating change
Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), OmniAb (OABI) and Astrana Health (ASTH)TipRanks · 2026/3/3
-
Rating change
A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $7 to $11Market Newswire · 2026/8/8
-
Truist Financial Maintains OmniAb(OABI.US) With Buy RatingMarket Newswire · 2026/8/18
-
Rating change
Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating, Announces Target Price $7Market Newswire · 2026/5/8
-
Rating change
Stifel Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11Market Newswire · 2025/8/7
-
Rating change
TR | OpenAI - 4o Initiates OmniAb(OABI.US) With Hold Rating, Announces Target Price $2Market Newswire · 2025/8/11
-
H.C. Wainwright Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11Market Newswire · 2026/10/7
-
Rating change
Analysts' Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)TipRanks · 2026/8/17
-
Rating change
Stifel Maintains OmniAb(OABI.US) With Buy Rating, Cuts Target Price to $9Market Newswire · 2025/11/6
-
Rating change
Benchmark Co. Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $6Market Newswire · 2025/8/9
-
Craig-Hallum Maintains OmniAb(OABI.US) With Buy RatingMarket Newswire · 2026/9/30
-
Rating change
H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)TipRanks · 2026/8/17
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 10:00:03 · For reference only, not investment advice and not tailored to your situation.